Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 60 entries
Sorted by: Best Match Show Resources per page
Pharmacological treatment with diacerein combined with mechanical stimulation affects the expression of growth factors in human chondrocytes.

Biochemistry and biophysics reports

Steinecker-Frohnwieser B, Kaltenegger H, Weigl L, Mann A, Kullich W, Leithner A, Lohberger B.
PMID: 28955780
Biochem Biophys Rep. 2017 Jul 01;11:154-160. doi: 10.1016/j.bbrep.2017.06.006. eCollection 2017 Sep.

BACKGROUND: Osteoarthritis (OA) as the main chronic joint disease arises from a disturbed balance between anabolic and catabolic processes leading to destructions of articular cartilage of the joints. While mechanical stress can be disastrous for the metabolism of chondrocytes,...

Cite
Steinecker-Frohnwieser B, Kaltenegger H, Weigl L, et al. Pharmacological treatment with diacerein combined with mechanical stimulation affects the expression of growth factors in human chondrocytes. Biochem Biophys Rep. 2017;11:154-160doi: 10.1016/j.bbrep.2017.06.006.
Steinecker-Frohnwieser, B., Kaltenegger, H., Weigl, L., Mann, A., Kullich, W., Leithner, A., & Lohberger, B. (2017). Pharmacological treatment with diacerein combined with mechanical stimulation affects the expression of growth factors in human chondrocytes. Biochemistry and biophysics reports, 11154-160. https://doi.org/10.1016/j.bbrep.2017.06.006
Steinecker-Frohnwieser, Bibiane, et al. "Pharmacological treatment with diacerein combined with mechanical stimulation affects the expression of growth factors in human chondrocytes." Biochemistry and biophysics reports vol. 11 (2017): 154-160. doi: https://doi.org/10.1016/j.bbrep.2017.06.006
Steinecker-Frohnwieser B, Kaltenegger H, Weigl L, Mann A, Kullich W, Leithner A, Lohberger B. Pharmacological treatment with diacerein combined with mechanical stimulation affects the expression of growth factors in human chondrocytes. Biochem Biophys Rep. 2017 Jul 01;11:154-160. doi: 10.1016/j.bbrep.2017.06.006. eCollection 2017 Sep. PMID: 28955780; PMCID: PMC5614688.
Copy Download .nbib Format: NLM
New Topical Agents for Treatment of Partial-thickness Burns in Children: A Review of Published Outcome Studies.

Wounds : a compendium of clinical research and practice

Dorsett-Martin WA, Persons B, Wysocki A, Lineaweaver W.
PMID: 25941828
Wounds. 2008 Nov;20(11):292-8.

 Evidence-based choices for treating burns in children are not well defined. Skin substitutes and contemporary dressings offer potential advantages over traditional treatment with topical antimicrobial agents in treating partial-thickness burns. Newer treatment modalities may reduce morbidity, financial burdens,...

Cite
Dorsett-Martin WA, Persons B, Wysocki A, et al. New Topical Agents for Treatment of Partial-thickness Burns in Children: A Review of Published Outcome Studies. Wounds. 2008;20(11):292-8
Dorsett-Martin, W. A., Persons, B., Wysocki, A., & Lineaweaver, W. (2008). New Topical Agents for Treatment of Partial-thickness Burns in Children: A Review of Published Outcome Studies. Wounds : a compendium of clinical research and practice, 20(11), 292-8.
Dorsett-Martin, Wanda A, et al. "New Topical Agents for Treatment of Partial-thickness Burns in Children: A Review of Published Outcome Studies." Wounds : a compendium of clinical research and practice vol. 20,11 (2008): 292-8.
Dorsett-Martin WA, Persons B, Wysocki A, Lineaweaver W. New Topical Agents for Treatment of Partial-thickness Burns in Children: A Review of Published Outcome Studies. Wounds. 2008 Nov;20(11):292-8. PMID: 25941828.
Copy Download .nbib Format: NLM
Using biobrane: techniques to make life easier.

Eplasty

Solanki NS, Nowak KM, Mackie IP, Greenwood JE.
PMID: 21187941
Eplasty. 2010 Dec 20;10:e70.

AIMS: To facilitate the use of Biobrane for those burn care practitioners not familiar with this material.METHODS: Two techniques have been developed through extensive use of Biobrane over many years, in both sheet and glove form. These techniques have...

Cite
Solanki NS, Nowak KM, Mackie IP, et al. Using biobrane: techniques to make life easier. Eplasty. 2010;10:e70
Solanki, N. S., Nowak, K. M., Mackie, I. P., & Greenwood, J. E. (2010). Using biobrane: techniques to make life easier. Eplasty, 10e70.
Solanki, Nicholas S, et al. "Using biobrane: techniques to make life easier." Eplasty vol. 10 (2010): e70.
Solanki NS, Nowak KM, Mackie IP, Greenwood JE. Using biobrane: techniques to make life easier. Eplasty. 2010 Dec 20;10:e70. PMID: 21187941; PMCID: PMC3008156.
Copy Download .nbib Format: NLM
Experience with biobrane: uses and caveats for success.

Eplasty

Greenwood JE, Clausen J, Kavanagh S.
PMID: 19633707
Eplasty. 2009 Jun 26;9:e25.

OBJECTIVE: To present some of our experience with Biobrane (a total of 703 patients in 7 years) in a range of uses in burn practice and to illustrate the caveats that we have found applicable in maintaining our success...

Cite
Greenwood JE, Clausen J, Kavanagh S. Experience with biobrane: uses and caveats for success. Eplasty. 2009;9:e25
Greenwood, J. E., Clausen, J., & Kavanagh, S. (2009). Experience with biobrane: uses and caveats for success. Eplasty, 9e25.
Greenwood, John E, et al. "Experience with biobrane: uses and caveats for success." Eplasty vol. 9 (2009): e25.
Greenwood JE, Clausen J, Kavanagh S. Experience with biobrane: uses and caveats for success. Eplasty. 2009 Jun 26;9:e25. PMID: 19633707; PMCID: PMC2704145.
Copy Download .nbib Format: NLM
The use of Biobrane® to dress split-thickness skin graft in paediatric burns.

Annals of burns and fire disasters

Farroha A, Frew Q, El-Muttardi N, Philp B, Dziewulski P.
PMID: 24133404
Ann Burns Fire Disasters. 2013 Jun 30;26(2):94-7.

Biobrane(®) is commonly used in paediatric burns to cover partial thickness burns and donor sites of split thickness skin (SSG). The purpose of this study is to evaluate the use of Biobrane(®) in dressing SSG adjacent to skin graft...

Cite
Farroha A, Frew Q, El-Muttardi N, et al. The use of Biobrane® to dress split-thickness skin graft in paediatric burns. Ann Burns Fire Disasters. 2013;26(2):94-7
Farroha, A., Frew, Q., El-Muttardi, N., Philp, B., & Dziewulski, P. (2013). The use of Biobrane® to dress split-thickness skin graft in paediatric burns. Annals of burns and fire disasters, 26(2), 94-7.
Farroha, A, et al. "The use of Biobrane® to dress split-thickness skin graft in paediatric burns." Annals of burns and fire disasters vol. 26,2 (2013): 94-7.
Farroha A, Frew Q, El-Muttardi N, Philp B, Dziewulski P. The use of Biobrane® to dress split-thickness skin graft in paediatric burns. Ann Burns Fire Disasters. 2013 Jun 30;26(2):94-7. PMID: 24133404; PMCID: PMC3793886.
Copy Download .nbib Format: NLM
Targeted molecular characterization shows differences between primary and secondary myelofibrosis.

Genes, chromosomes & cancer

Courtier F, Garnier S, Carbuccia N, Guille A, Adélaide J, Chaffanet M, Hirsch P, Paz DL, Slama B, Vey N, Ugo V, Delhommeau F, Rey J, Birnbaum D, Murati A.
PMID: 31340059
Genes Chromosomes Cancer. 2019 Jul 24; doi: 10.1002/gcc.22789. Epub 2019 Jul 24.

INTRODUCTION: In BCR-ABL1-negative myeloproliferative neoplasms, myelofibrosis (MF) is either primary (PMF) or secondary (SMF) to polycythemia vera or essential thrombocythemia. MF is characterized by an increased risk of transformation to acute myeloid leukemia (AML) and a shortened life expectancy.METHODS:...

Cite
Courtier F, Garnier S, Carbuccia N, et al. Targeted molecular characterization shows differences between primary and secondary myelofibrosis. Genes Chromosomes Cancer. 2019;doi: 10.1002/gcc.22789.
Courtier, F., Garnier, S., Carbuccia, N., Guille, A., Adélaide, J., Chaffanet, M., Hirsch, P., Paz, D. L., Slama, B., Vey, N., Ugo, V., Delhommeau, F., Rey, J., Birnbaum, D., & Murati, A. (2019). Targeted molecular characterization shows differences between primary and secondary myelofibrosis. Genes, chromosomes & cancer, . https://doi.org/10.1002/gcc.22789
Courtier, Frédéric, et al. "Targeted molecular characterization shows differences between primary and secondary myelofibrosis." Genes, chromosomes & cancer vol. (2019). doi: https://doi.org/10.1002/gcc.22789
Courtier F, Garnier S, Carbuccia N, Guille A, Adélaide J, Chaffanet M, Hirsch P, Paz DL, Slama B, Vey N, Ugo V, Delhommeau F, Rey J, Birnbaum D, Murati A. Targeted molecular characterization shows differences between primary and secondary myelofibrosis. Genes Chromosomes Cancer. 2019 Jul 24; doi: 10.1002/gcc.22789. Epub 2019 Jul 24. PMID: 31340059.
Copy Download .nbib Format: NLM
Early definitive treatment of partial-thickness alkali burns with tangential excision and biobrane.

Archives of plastic surgery

Kok YO, Chong SJ, Basuki A, Tan BK.
PMID: 29506336
Arch Plast Surg. 2018 Mar;45(2):193-195. doi: 10.5999/aps.2017.00507. Epub 2018 Mar 05.

No abstract available.

Cite
Kok YO, Chong SJ, Basuki A, et al. Early definitive treatment of partial-thickness alkali burns with tangential excision and biobrane. Arch Plast Surg. 2018;45(2):193-195doi: 10.5999/aps.2017.00507.
Kok, Y. O., Chong, S. J., Basuki, A., & Tan, B. K. (2018). Early definitive treatment of partial-thickness alkali burns with tangential excision and biobrane. Archives of plastic surgery, 45(2), 193-195. https://doi.org/10.5999/aps.2017.00507
Kok, Yee Onn, et al. "Early definitive treatment of partial-thickness alkali burns with tangential excision and biobrane." Archives of plastic surgery vol. 45,2 (2018): 193-195. doi: https://doi.org/10.5999/aps.2017.00507
Kok YO, Chong SJ, Basuki A, Tan BK. Early definitive treatment of partial-thickness alkali burns with tangential excision and biobrane. Arch Plast Surg. 2018 Mar;45(2):193-195. doi: 10.5999/aps.2017.00507. Epub 2018 Mar 05. PMID: 29506336; PMCID: PMC5869426.
Copy Download .nbib Format: NLM
The effects of educational curricula and training on LGBT-specific health issues for healthcare students and professionals: a mixed-method systematic review.

Journal of the International AIDS Society

Sekoni AO, Gale NK, Manga-Atangana B, Bhadhuri A, Jolly K.
PMID: 28782330
J Int AIDS Soc. 2017 Jul 19;20(1):21624. doi: 10.7448/IAS.20.1.21624.

INTRODUCTION: Poor access of lesbian, gay, bisexual and transgender (LGBT) people to healthcare providers with clinical and cultural competency contributes to health inequalities between heterosexual/cisgender and LGBT people. This systematic review assesses the effect of educational curricula and training...

Cite
Sekoni AO, Gale NK, Manga-Atangana B, et al. The effects of educational curricula and training on LGBT-specific health issues for healthcare students and professionals: a mixed-method systematic review. J Int AIDS Soc. 2017;20(1):21624doi: 10.7448/IAS.20.1.21624.
Sekoni, A. O., Gale, N. K., Manga-Atangana, B., Bhadhuri, A., & Jolly, K. (2017). The effects of educational curricula and training on LGBT-specific health issues for healthcare students and professionals: a mixed-method systematic review. Journal of the International AIDS Society, 20(1), 21624. https://doi.org/10.7448/IAS.20.1.21624
Sekoni, Adekemi Oluwayemisi, et al. "The effects of educational curricula and training on LGBT-specific health issues for healthcare students and professionals: a mixed-method systematic review." Journal of the International AIDS Society vol. 20,1 (2017): 21624. doi: https://doi.org/10.7448/IAS.20.1.21624
Sekoni AO, Gale NK, Manga-Atangana B, Bhadhuri A, Jolly K. The effects of educational curricula and training on LGBT-specific health issues for healthcare students and professionals: a mixed-method systematic review. J Int AIDS Soc. 2017 Jul 19;20(1):21624. doi: 10.7448/IAS.20.1.21624. PMID: 28782330; PMCID: PMC5577719.
Copy Download .nbib Format: NLM
Comparative effectiveness of Biobrane®, RECELL® Autologous skin Cell suspension and Silver dressings in partial thickness paediatric burns: BRACS randomised trial protocol.

Burns & trauma

Bairagi A, Griffin B, Tyack Z, Vagenas D, McPhail SM, Kimble R.
PMID: 31696127
Burns Trauma. 2019 Oct 31;7:33. doi: 10.1186/s41038-019-0165-0. eCollection 2019.

BACKGROUND: Mixed partial thickness burns are the most common depth of burn injury managed at a large Australian paediatric hospital specialty burns unit. Prolonged time until re-epithelialisation is associated with increased burn depth and scar formation. Whilst current wound...

Cite
Bairagi A, Griffin B, Tyack Z, et al. Comparative effectiveness of Biobrane®, RECELL® Autologous skin Cell suspension and Silver dressings in partial thickness paediatric burns: BRACS randomised trial protocol. Burns Trauma. 2019;7:33doi: 10.1186/s41038-019-0165-0.
Bairagi, A., Griffin, B., Tyack, Z., Vagenas, D., McPhail, S. M., & Kimble, R. (2019). Comparative effectiveness of Biobrane®, RECELL® Autologous skin Cell suspension and Silver dressings in partial thickness paediatric burns: BRACS randomised trial protocol. Burns & trauma, 733. https://doi.org/10.1186/s41038-019-0165-0
Bairagi, Anjana, et al. "Comparative effectiveness of Biobrane®, RECELL® Autologous skin Cell suspension and Silver dressings in partial thickness paediatric burns: BRACS randomised trial protocol." Burns & trauma vol. 7 (2019): 33. doi: https://doi.org/10.1186/s41038-019-0165-0
Bairagi A, Griffin B, Tyack Z, Vagenas D, McPhail SM, Kimble R. Comparative effectiveness of Biobrane®, RECELL® Autologous skin Cell suspension and Silver dressings in partial thickness paediatric burns: BRACS randomised trial protocol. Burns Trauma. 2019 Oct 31;7:33. doi: 10.1186/s41038-019-0165-0. eCollection 2019. PMID: 31696127; PMCID: PMC6822367.
Copy Download .nbib Format: NLM
Solvate sponge crystals of (DMF).

Chemical science

Prakash P, Ardhra S, Fall B, Zdilla MJ, Wunder SL, Venkatnathan A.
PMID: 34168793
Chem Sci. 2021 Mar 01;12(15):5574-5581. doi: 10.1039/d0sc06455f.

A new type of crystalline solid, termed "solvate sponge crystal", is presented, and the chemical basis of its properties are explained for a melt- and press-castable solid sodium ion conductor. X-ray crystallography and atomistic simulations reveal details of atomic...

Cite
Prakash P, Ardhra S, Fall B, et al. Solvate sponge crystals of (DMF). Chem Sci. 2021;12(15):5574-5581doi: 10.1039/d0sc06455f.
Prakash, P., Ardhra, S., Fall, B., Zdilla, M. J., Wunder, S. L., & Venkatnathan, A. (2021). Solvate sponge crystals of (DMF). Chemical science, 12(15), 5574-5581. https://doi.org/10.1039/d0sc06455f
Prakash, Prabhat, et al. "Solvate sponge crystals of (DMF)." Chemical science vol. 12,15 (2021): 5574-5581. doi: https://doi.org/10.1039/d0sc06455f
Prakash P, Ardhra S, Fall B, Zdilla MJ, Wunder SL, Venkatnathan A. Solvate sponge crystals of (DMF). Chem Sci. 2021 Mar 01;12(15):5574-5581. doi: 10.1039/d0sc06455f. PMID: 34168793; PMCID: PMC8179650.
Copy Download .nbib Format: NLM
PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Hyperglycemic Mice Increases the Risk of Hemorrhagic Transformation of Ischemic Stroke.

Stroke

Nativel B, Ramin-Mangata S, Couret D, Planesse C, Roche M, Gallo A, Meilhac O, Lambert G, Bourane S.
PMID: 34315254
Stroke. 2021 Aug;52(9):e545-e547. doi: 10.1161/STROKEAHA.121.035677. Epub 2021 Jul 28.

[Figure: see text].

Cite
Nativel B, Ramin-Mangata S, Couret D, et al. PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Hyperglycemic Mice Increases the Risk of Hemorrhagic Transformation of Ischemic Stroke. Stroke. 2021;52(9):e545-e547doi: 10.1161/STROKEAHA.121.035677.
Nativel, B., Ramin-Mangata, S., Couret, D., Planesse, C., Roche, M., Gallo, A., Meilhac, O., Lambert, G., & Bourane, S. (2021). PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Hyperglycemic Mice Increases the Risk of Hemorrhagic Transformation of Ischemic Stroke. Stroke, 52(9), e545-e547. https://doi.org/10.1161/STROKEAHA.121.035677
Nativel, Brice, et al. "PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Hyperglycemic Mice Increases the Risk of Hemorrhagic Transformation of Ischemic Stroke." Stroke vol. 52,9 (2021): e545-e547. doi: https://doi.org/10.1161/STROKEAHA.121.035677
Nativel B, Ramin-Mangata S, Couret D, Planesse C, Roche M, Gallo A, Meilhac O, Lambert G, Bourane S. PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Hyperglycemic Mice Increases the Risk of Hemorrhagic Transformation of Ischemic Stroke. Stroke. 2021 Aug;52(9):e545-e547. doi: 10.1161/STROKEAHA.121.035677. Epub 2021 Jul 28. PMID: 34315254.
Copy Download .nbib Format: NLM
Improved survival in multiple myeloma during the 2005-2009 and 2010-2014 periods.

Leukemia

Corre J, Perrot A, Hulin C, Caillot D, Stoppa AM, Facon T, Leleu X, Dib M, Karlin L, Moreau P, Mohty M, Mariette C, Fontan J, Marolleau JP, Demarquette H, Slama B, Voillat L, Macro M, Orsini-Piocelle F, Brechignac S, Rey P, Collet P, Tiab M, Belhadj K, Lifermann F, Clement-Filliatre L, Sohn C, Richez V, Avet-Loiseau H.
PMID: 34099876
Leukemia. 2021 Dec;35(12):3600-3603. doi: 10.1038/s41375-021-01250-0. Epub 2021 Jun 07.

No abstract available.

Cite
Corre J, Perrot A, Hulin C, et al. Improved survival in multiple myeloma during the 2005-2009 and 2010-2014 periods. Leukemia. 2021;35(12):3600-3603doi: 10.1038/s41375-021-01250-0.
Corre, J., Perrot, A., Hulin, C., Caillot, D., Stoppa, A. M., Facon, T., Leleu, X., Dib, M., Karlin, L., Moreau, P., Mohty, M., Mariette, C., Fontan, J., Marolleau, J. P., Demarquette, H., Slama, B., Voillat, L., Macro, M., Orsini-Piocelle, F., Brechignac, S., Rey, P., Collet, P., Tiab, M., Belhadj, K., Lifermann, F., Clement-Filliatre, L., Sohn, C., Richez, V., Avet-Loiseau, H. (2021). Improved survival in multiple myeloma during the 2005-2009 and 2010-2014 periods. Leukemia, 35(12), 3600-3603. https://doi.org/10.1038/s41375-021-01250-0
Corre, Jill, et al. "Improved survival in multiple myeloma during the 2005-2009 and 2010-2014 periods." Leukemia vol. 35,12 (2021): 3600-3603. doi: https://doi.org/10.1038/s41375-021-01250-0
Corre J, Perrot A, Hulin C, Caillot D, Stoppa AM, Facon T, Leleu X, Dib M, Karlin L, Moreau P, Mohty M, Mariette C, Fontan J, Marolleau JP, Demarquette H, Slama B, Voillat L, Macro M, Orsini-Piocelle F, Brechignac S, Rey P, Collet P, Tiab M, Belhadj K, Lifermann F, Clement-Filliatre L, Sohn C, Richez V, Avet-Loiseau H. Improved survival in multiple myeloma during the 2005-2009 and 2010-2014 periods. Leukemia. 2021 Dec;35(12):3600-3603. doi: 10.1038/s41375-021-01250-0. Epub 2021 Jun 07. PMID: 34099876.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 60 entries